CAS: 38231-86-6 - Valienamine
Fórmula:C7H13NO4
InChI:InChI=1S/C7H13NO4/c8-4-1-3(2-9)5(10)7(12)6(4)11/h1,4-7,9-12H,2,8H2/t4-,5+,6-,7-/m0/s1
Clave InChI:InChIKey=XPHOBMULWMGEBA-VZFHVOOUSA-N
SMILES:OCC1=CC(N)C(O)C(O)C1O
- Sinónimos:
- (1S,2S,3R,4S,5S)-5-amino-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
- (1S,2S,3R,6S)-6-Amino-4-(hydroxymethyl)-4-cyclohexene-1,2,3-triol
- (1S,2S,3R,6S)-6-amino-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol
- 4-Cyclohexene-1,2,3-triol, 6-amino-4-(hydroxymethyl)-, (1S,2S,3R,6S)-
- 4-Cyclohexene-1,2,3-triol, 6-amino-4-(hydroxymethyl)-, [1S-(1α,2β,3α,6α)]-
- 6-Amino-4-(Hydroxymethyl)Cyclohex-4-Ene-1,2,3-Triol
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Valienamine REF: 7W-GC1885CAS: 38231-86-6 | - - - | A consultar | Mié 08 Ene 25 |
 | Valienamine REF: TM-T73978CAS: 38231-86-6 | - - - | A consultar | Mié 08 Ene 25 |
 | (+) Valienamine REF: 4Z-V-074001CAS: 38231-86-6 | - - - | A consultar | Mar 14 Ene 25 |
 | Valienamine HCl REF: 3D-MV11213CAS: 38231-86-6 | Min. 95% | A consultar | Mar 18 Feb 25 |
Ref: 7W-GC1885
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 8 de Enero de 2025
Valienamine
CAS:38231-86-6
Valienamine: an alpha-glucosidase inhibitor found in validamycin A and antidiabetic acarbose.
Fórmula:
C7H13NO4
Forma y color:
Liquid
Peso molecular:
175.18
Ref: TM-T73978
| 5mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 8 de Enero de 2025
Ref: 4Z-V-074001
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Valienamine HCl
CAS:38231-86-6
Glucosidase Inhibitor
Fórmula:
C7H13NO4
Pureza:
Min. 95%
Forma y color:
White to off-white solid.
Peso molecular:
175.18 g/mol
Ref: 3D-MV11213
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 500µg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
